CDT
CDT
NASDAQ · Life Sciences Tools & Services

Cdt Equity Inc

$5.10
-4.25 (-45.45%)
As of Mar 31, 10:16 PM ET ·
Financial Highlights (FY 2025)
Revenue
1.43M
Net Income
94.6K
Gross Margin
55.6%
Profit Margin
6.6%
Rev Growth
+2.2%
D/E Ratio
0.55
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 55.6% 55.6% 55.6%
Operating Margin 5.8% 6.5% 6.7%
Profit Margin 6.6% 6.3% 5.9%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.43M 1.43M 1.42M
Gross Profit 792.1K 792.7K 788.2K
Operating Income 82.7K 92.8K 94.7K
Net Income 94.6K 89.7K 83.3K
Gross Margin 55.6% 55.6% 55.6%
Operating Margin 5.8% 6.5% 6.7%
Profit Margin 6.6% 6.3% 5.9%
Rev Growth +2.2% +9.0% -5.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 527.4K 461.1K 510.4K
Total Equity 961.8K 858.5K 854.7K
D/E Ratio 0.55 0.54 0.60
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 137.8K 130.6K 129.8K
Free Cash Flow 64.4K 50.5K 73.0K